he's alos on BOD of an early stage bio..called Portage Biotech PTGEF....load up
His price target may be low, I am looking for 13 to 15 after
clean PI results.
I've got about 5,000 shares at an average of over $9. Bio's can move up in a flash. Just been holding for a few years now, waiting for that breakthrough. R&D is tough, but ARWR has been pulled from the brink thanks to Anzalone.
helps if you can explain who Jim Melllon is
Sentiment: Strong Buy
Jim Mellon has a book out too and he mentions ARWR as one of his promising picks